The Ontario government’s decision to shutter multiple supervised drug consumption sites in Toronto runs counter to the expert opinions it sought about one of those sites.

Dan Werb, executive director of the Centre on Drug Policy Evaluation at St. Michael’s Hospital, co-authored a study published in the medical journal The Lancet earlier this year, which showed a two-thirds reduction in overdose mortality in Toronto within five kilometres of a supervised consumption site.

“It’s quite odd to me that you should shut down what is a really effective gateway into a treatment and care system at the same time that you’re investing so much into that same treatment care system,” he said Wednesday.

“It’s sort of like building a hospital and forgetting to build doors into it.”

For more information, read the full article here.